Hosseinzadeh, Shahnaz
Imani, Mahsa
Pourfarzi, Farhad
Jafari, Narjes
AbedianKenari, Saeid http://orcid.org/0000-0002-4287-2670
Safarzadeh, Elham http://orcid.org/0000-0001-6160-8923
Funding for this research was provided by:
Digestive Disease Research Center, Ardabil University of Medical Sciences (1003253)
Article History
Received: 30 December 2023
Accepted: 5 February 2024
First Online: 9 April 2024
Declarations
:
: Shahnaz Hosseinzadeh, Mahsa Imani, Farhad Pourfarzi, Narjes Jafari, Saeid AbedianKenari, and Elham Safarzadeh declare that they have no conflict of interest that might be relevant to the contents of this manuscript.
: The study entitled Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: A Potential Immunotherapy for Gastric Cancer was approved by the Research Ethics Committee of Mazandaran University of Medical Sciences (IR.MAZUMS.REC.1398.1295), Sari, Iran, in accordance with the guidelines.
: Informed consent was obtained in accordance with the principles of the revised Declaration of Helsinki and approved by the Research Ethics Committee of Mazandaran University of Medical Sciences (IR.MAZUMS.REC.1398.1295) in Sari, Iran.